Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria

被引：0
|
作者：
Jonathan Graham
Doreen McBride
Donald Stull
Anna Halliday
Stamatia Theodora Alexopoulos
Maria-Magdalena Balp
Matthew Griffiths
Ion Agirrezabal
Torsten Zuberbier
Alan Brennan
机构：
[1] RTI Health Solutions,Department of Dermatology and Allergy, Allergy
[2] RTI Health Solutions,Centre
[3] Novartis Pharmaceuticals UK Limited,Charité
[4] Novartis Pharma AG,undefined
[5] Costello Medical Consulting Ltd,undefined
[6] Charité-University Hospital Berlin,undefined
[7] University of Sheffield,undefined
来源：
PharmacoEconomics | 2016年 / 34卷
关键词：
Urticaria; Scenario Analysis; Omalizumab; Chronic Urticaria; Spontaneous Remission;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：815 / 827
页数：12
相关论文
共 50 条
  • [31] Combined use of ciclosporin and omalizumab for the treatment of chronic spontaneous urticaria
    Smith, Helin
    Denman, Sarah
    Ford, Kate
    Toolan, John
    Savic, Sinisa
    CLINICAL AND EXPERIMENTAL ALLERGY, 2019, 49 (12): : 1665 - 1665
  • [32] Efficacy of Omalizumab in Treatment-Resistant Chronic Spontaneous Urticaria
    Tabanlioglu-Onan, Duru
    Oktem, Ayse
    Yalcin, Basak
    Artuz, Ferda
    ASTIM ALLERJI IMMUNOLOJI, 2019, 17 (01): : 41 - 46
  • [33] Omalizumab treatment for chronic spontaneous urticaria: data from Turkey
    Kara, Rabia Oztas
    Dikicier, Bahar Sevimli
    Yaldiz, Mahizer
    Koku, Busra
    Cosansu, Nur Cihan
    Solak, Berna
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2022, 39 (04): : 704 - 707
  • [34] Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: a critical appraisal
    Durack, A.
    Matin, R. N.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (01) : 10 - 13
  • [35] Omalizumab treatment in adolescents with chronic spontaneous urticaria: Efficacy and safety
    Kahveci, M.
    Soyer, O.
    Buyuktiryaki, B.
    Sekerel, B. E.
    Sahiner, U. M.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2020, 48 (04) : 368 - 373
  • [36] Omalizumab treatment in children with chronic spontaneous urticaria: Efficacy and safety
    Kahveci, M.
    Sahiner, U. M.
    Buyuktiryaki, B.
    Sekerel, B. E.
    Soyer, O.
    ALLERGY, 2019, 74 : 867 - 868
  • [37] Omalizumab in chronic spontaneous urticaria treatment: Real life experiences
    Engin, Burhan
    Celik, Ugur
    Birben, Aslihan Ozge
    Askin, Ozge
    Kutlubay, Zekayi
    Serdaroglu, Server
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2019, 53 (04): : 145 - 149
  • [38] Treatment response to omalizumab in patients with refractory chronic spontaneous urticaria
    Syrigos, Nikolaos
    Grapsa, Dimitra
    Zande, Maria
    Tziotou, Marianna
    Syrigou, Ekaterini
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2018, 57 (04) : 417 - 422
  • [39] Multicentre experience of home omalizumab treatment for chronic spontaneous urticaria
    Denman, Sarah
    El-Shanaway, Tariq
    Carne, Emily
    Devlin, Lisa
    Savic, Sinisa
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2020, 27 (06) : 367 - 368
  • [40] Omalizumab re-treatment rates in chronic spontaneous urticaria
    Khan, S.
    Sholtysek, S.
    EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 52 (04) : 187 - 189
12345